Public Health

New approach needed to tackle rising drug prices

The proliferation of high-cost medicines and rising drug prices are increasing pressures on public health spending and calling into question the pharmaceutical industry’s pricing strategies. According to a new report from the OECD, ‘ New Health Technologies: Managing Access, Value and Sustainability’, pharmaceutical spending is increasingly skewed towards high-cost products. The launch prices of drugs […]

New approach needed to tackle rising drug prices Read More »

Big Data in Health

A new study on Big Data in Public Health, Telemedicine and Healthcare identifies examples of the use of Big Data in Health, and puts forward recommendations covering 10 relevant fields: awareness raising, education and training, data sources, open data and data sharing, applications and purposes, data analysis, governance of data access and use, standards, funding

Big Data in Health Read More »

Guidance on endocrine disruptors

The European Food Safety Authority (EFSA) and the European Chemicals Agency (ECHA) are developing scientific guidance to enable identification of endocrine disruptors. In 2016 the European Commission proposed science-based criteria for identifying endocrine disruptors in the context of EU legislation on pesticides and biocides. Discussions with Member States and experts are on-going and the criteria

Guidance on endocrine disruptors Read More »

HIV & Hepatitis in Europe

There are 53 countries in the WHO European Region and within those countries there are 15 million people living with hepatitis C and 13.3 million people living with hepatitis B, the vast majority of whom are unaware of their infection and therefore at risk of developing cirrhosis or liver cancer. On average, fewer than 3{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96}

HIV & Hepatitis in Europe Read More »

How to do better health reform

Health systems are continually being reformed but why? And how? An article in ‘Healthcare Reform, Quality and Safety: Perspectives, Participants, Partnerships and Prospects in 30 Countries’ analyses the impact that health-reform initiatives have had on the quality and safety of care in low-, middle- and high-income countries—Argentina, Australia, Brazil, Chile, China, Denmark, England, Ghana, Germany,

How to do better health reform Read More »

Scroll to Top